Bioxyne

Bioxyne's Breathe Life Sciences Locks In $50 Million Two-Year Deal with German Pharma Distributor

Medical

Bioxyne's Breathe Life Sciences Locks In $50 Million Two-Year Deal with German Pharma Distributor

May 12, 2026

Bioxyne Secures Inaugural Medicinal Cannabis Flower Deal in Costa Rica

Medical

Bioxyne Secures Inaugural Medicinal Cannabis Flower Deal in Costa Rica

May 11, 2026

Bioxyne Posts 24% Quarterly Revenue Jump, Reaffirms Full-Year Targets

Finance

Bioxyne Posts 24% Quarterly Revenue Jump, Reaffirms Full-Year Targets

April 21, 2026

Bioxyne's BLS Unit Secures Cannabis Manufacturing Contract with Aurora

Medical

Bioxyne's BLS Unit Secures Cannabis Manufacturing Contract with Aurora

April 01, 2026

Roadside Drug Testing Reform Could Double Australia's Medicinal Cannabis Market, Says Bioxyne

Medical

Roadside Drug Testing Reform Could Double Australia's Medicinal Cannabis Market, Says Bioxyne

March 25, 2026

Medical

Bioxyne CEO Flags Credibility Concerns Over Recreational-Style Cannabis Branding

March 12, 2026

Bioxyne raises FY26 earnings outlook on the back of first-half margin gains

Finance

Bioxyne raises FY26 earnings outlook on the back of first-half margin gains

February 26, 2026

Industry roundup: MedReleaf adds new products across ANZ; Bioxyne ships first psilocybin capsules; Greencare Clinic appoints medical lead

Medical

Industry roundup: MedReleaf adds new products across ANZ; Bioxyne ships first psilocybin capsules; Greencare Clinic appoints medical lead

February 11, 2026

Bioxyne Posts Best-Ever Quarterly Revenue as Cannabis and New Products Drive Growth

Finance

Bioxyne Posts Best-Ever Quarterly Revenue as Cannabis and New Products Drive Growth

January 28, 2026

Bioxyne targets Costa Rica and Panama with THC pastille supply agreement

Finance

Bioxyne targets Costa Rica and Panama with THC pastille supply agreement

December 12, 2025

Curaleaf International CEO details measured approach to Australian cannabis market entry

Medical

Curaleaf International CEO details measured approach to Australian cannabis market entry

November 27, 2025

Victorian cannabis reform under fire; MCA releases national prescriber guide; Bioxyne lands A$1.7m for UK GMP site

Medical

Victorian cannabis reform under fire; MCA releases national prescriber guide; Bioxyne lands A$1.7m for UK GMP site

November 17, 2025

Cann Group finalises NAB debt deal; Bioxyne unit ships GMP-certified MDMA capsules

Medical

Cann Group finalises NAB debt deal; Bioxyne unit ships GMP-certified MDMA capsules

November 11, 2025

Medical

Breathe Life Sciences brings Curaleaf's medical inhalation device to Australian market

November 03, 2025

Finance

Bioxyne Posts Best-Ever Quarterly Revenue Despite Widening Cash Outflows

October 30, 2025

FY25 pay packets: what Australia's listed cannabis executives took home

Finance

FY25 pay packets: what Australia's listed cannabis executives took home

October 22, 2025

AFR innovation shortlist, Frankfurt listing, and Nimbin cannabis symposium: Industry news in brief

Medical

AFR innovation shortlist, Frankfurt listing, and Nimbin cannabis symposium: Industry news in brief

October 13, 2025

Medical

Breathe Life Sciences wins ARTG Listings for Dr Watson Products, Opening Door to Global Exports

October 09, 2025

Trump's CBD endorsement sends Wall Street cannabis stocks soaring, lifting local industry hopes

Finance

Trump's CBD endorsement sends Wall Street cannabis stocks soaring, lifting local industry hopes

October 01, 2025

Industry Roundup: Epsilon's GMP Wins EU and UK Recognition; AGH Banks $2.6m; Zelira Taps Director Loans; Bioxyne Ships $5m German Cannabis Order

Finance

Industry Roundup: Epsilon's GMP Wins EU and UK Recognition; AGH Banks $2.6m; Zelira Taps Director Loans; Bioxyne Ships $5m German Cannabis Order

September 17, 2025

Bioxyne Posts First Major Profit as Australian Medicinal Cannabis Revenue Triples

Finance

Bioxyne Posts First Major Profit as Australian Medicinal Cannabis Revenue Triples

August 29, 2025

Personnel Moves and Legal Action: ANTG Welcomes Wragg, Bioxyne Sues Major Shareholder, Epsilon Names Kaplon Secretary

Legal

Personnel Moves and Legal Action: ANTG Welcomes Wragg, Bioxyne Sues Major Shareholder, Epsilon Names Kaplon Secretary

August 28, 2025